When Incyte Genomics, then a bioinformatics company based in Palo Alto, California, acquired Synteni for $90m in 1997, Affymetrix immediately sued Incyte for patent infringement.
所以当IncyteGenomics，一个同样位于帕洛阿尔托的生物技术公司于1997年以9000万美元的价格收购Synteni时，Affymetrix马上作出以专利侵权起诉了Incyte公司。
Meanwhile, Incyte, a pharmaceutical company in Wilmington, Delaware, presented promising results from a smaller trial of its own kinase inhibitor. And a paper published in September by the.
与此同时，特拉华州威尔明顿的Incyte制药公司，提出了自己的激酶抑制剂小范围试验的良结果。
Meanwhile, Incyte, a pharmaceutical company in Wilmington, Delaware, presented promising results from a smaller trial of its own kinase inhibitor. And a paper published in September by the.
与此同时，特拉华州威尔明顿的Incyte制药公司，提出了自己的激酶抑制剂小范围试验的良结果。
应用推荐